Across TCGA pan-cancer cohorts, PPEF1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated PPEF1 data layer compared with 4 for mutation status.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher PPEF1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated PPEF1 expression acts as an unfavorable survival marker, although some lineages such as DLBC and LUSC show a favorable association.
KIRP, ACC, and UVM are the cancer types where PPEF1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.